Health & Biotech
Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®. With NanoCelle® the company has launched and is investigating a broad range of prescription and non-prescription solutions for patient needs across a variety of therapeutic areas including: pain management, mental health, gut health, diabetes, and allergies.
Medlab specialise in solutions that can provide improved bioavailability leading to better outcomes, fewer side effects and improved quality of life through agile innovative research and expertise in both large and small molecule delivery, throughout the entire supply chain process, from concept to the manufactured end product.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Good news for pot stocks as US approves its first medical cannabis drug
Health & Biotech
Canada’s got a nice marijuana buzz but US is the real prize for ASX pot stocks
Health & Biotech
Medlab kicks off cannabis spray trial for cancer patients at Royal North Shore hospital
Health & Biotech
Here’s how much money ASX cannabis stocks made last quarter
Health & Biotech
Which ASX pot stocks hold those golden Aussie cannabis licences
Health & Biotech
Why Medlab has a head start among cannabis stocks
News
ASX opens down 2.6pc after Dow plunge; cannabis, crypto stocks hurt yesterday
Health & Biotech
Cannabis play MedLab Clinical hits record high after raising $24m
Health & Biotech
Medlab rallies 27pc as it joins the licensed cannabis elite
Health & Biotech
It’s cannabis-induced euphoria as ASX pot stocks double in a month
Health & Biotech